The purpose of the study was to characterize and encapsulate within 8 weeks a lipid based formulation in a Licaps® Drug Delivery System (Licaps® DDS) intended for a clinical trial to obtain Proof-of-Concept for an innovative treatment of gastro-intestinal diseases developed by Synergy Pharmaceuticals.
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest CHI content
Latest briefing from the Knowledge Center